Skip to content

Contact +44 (0) 20 7060 7474 email us

Clinical Trials

Glucose Monitoring Clinical Trial Analysis

 

Publication Date July 2009
Publisher Global Markets Direct
Product Type
Pages 60
ISBN Number not applicable
Product Code GMD02896

Price

£660.00
approximately: $999 | €737

pdf

Buy Now

Order above formats by FAX

Order by Fax

Summary

Global Markets Direct's "Glucose Monitoring Clinical Trials Analysis" is an essential source of data and information pertaining to product clinical trials being carried out by Glucose Monitoring manufacturers, globally. The report provides exhaustive information on each clinical investigation study with coverage detailed coverage on the pipeline products these trials are being carried out for.

Scope

  • The report provides analysis and review of the key clinical trials being carried out globally and across key Glucose Monitoring market categories - Blood Glucose Test Strips,Traditional Glucose Meters,Continuous Glucose Monitoring Systems
  • The report covers information on each product being clinically tested with detailed coverage on the pipeline product profile, the indication it's being investigated for etc.
  • The report provides an in-depth analysis of the clinical trials with information on trial phase, trial 0status, trial acronym, purpose, inclusion and exclusion criteria, description, design, intervention, investigator information, primary and secondary end-points and trial results
  • The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Global Markets Direct's team of industry experts.

Reasons to Buy

  • Effectively plan your Mergers and Acquisitions and partnership strategies by identifying companies with the most promising pipeline.
  • Stay ahead of the information curve in the fast changing Glucose Monitoring market.
  • Plan in-licensing and out-licensing opportunities through review of pipeline products and technologies.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Proactively plan and execute your competitive strategies by identifying clinical trials status of the leading competitive products in pipeline.
  • Stay ahead of competition by understanding the changing competitive landscape in specific geographies.

Contents

  • 1 List of Tables
  • 1.2 List of Figures
  • 2 Glucose Monitoring Clinical Trials
    • 2.1 Glucose Monitoring Clinical Trial By Equipment Type
    • 2.2 Glucose Monitoring Clinical Trials By Trial Phase and Trial Status
    • 2.3 Glucose Monitoring Pipeline Products By Development Stage
    • 2.4 Glucose Monitoring Pipeline Products By Therapy Area
    • 2.5 Glucose Monitoring Pipeline Products By News Summary
    • 2.6 Glucose Monitoring SENTRIS-100
      • 2.6.1 First Hypoglycemic Clamping Study of Sentris-100 Completed
    • 2.7 Glucose Monitoring OmniPod Personal Diabetes Manager
      • 2.7.1 OmniPod Insulin Management System To Assess The Comfort, Function, And Use Of The OmniPod system (Pod) Compared With The Use Of A Conventional Insulin Pump
      • 2.7.2 In Silico Benchmark Platform For Artificial Cell - A Dynamic Simulator For Closed-Loop Control With Hardware-In-The-Loop
    • 2.8 Glucose Monitoring GLUCOCARD X-METER GT-1910
      • 2.8.1 Evaluation Of Glucocard X-Meter Glucose Monitoring System
    • 2.9 Glucose Monitoring Scout DS
      • 2.9.1 A Prospective, Multi-Center, Paired Data, Cohort Screening Trial Comparing SCOUT to the Fasting Plasma Glucose Test in Subjects at Risk for Diabetes
      • 2.9.2 Noninvasive Skin Spectroscopy For Diabetes Screening
      • 2.9.3 Noninvasive Skin Spectroscopy For Diabetes Screening
      • 2.9.4 A Calibration Trial To Assure The Ability Of Scout DS In People At Risk For Type 2 Diabetes
      • 2.9.5 A Prototype Study-Scout DS
      • 2.9.6 A Cross-Sectional Study Comparing Noninvasive Skin Fluorescence To Coronary Artery Calcification Measured By Rapid Computed Tomography
      • 2.9.7 A Cross-Sectional Study Comparing Noninvasive Skin Fluorescence To Coronary Artery Calcification Measured By Rapid Computed Tomography
    • 2.10 Glucose Monitoring Non-invasive continuous glucose monitor
      • 2.10.1 Repetition Trial at the University Hospital Zrich
      • 2.10.2 Solianis' Multisensor System In Home-Use Trial
    • 2.11 Glucose Monitoring SpectRx Glucose Monitoring
      • 2.11.1 CDC Study Shows Spectrx Continuous Glucose Monitor Tracks Glucose Levels In Children And Adults
    • 2.12 Glucose Monitoring Sensys GTS
      • 2.12.1 Evaluation of a non-invasive glucose monitor through an independent multi-center clinical study
    • 2.13 Glucose Monitoring NBM-200G
      • 2.13.1 The accuracy, safety and efficacy of the NBM-200G were demonstrated in a clinical trial which assessed a full range of blood glucose levels and a variety of glucose monitoring applications
      • 2.13.2 Performance Of A Non-Invasive Continuous Glucose Monitor In A Multi-Center Clinical Trial
    • 2.14 Glucose Monitoring OneTouch Glucose Meter
      • 2.14.1 A 54 Week Open, Randomized, Parallel Arm, Controlled Study Designed to Assess the Clinical Benefit of the OneTouch Ultra2 System
    • 2.15 Glucose Monitoring Luminous Medical Glucose Measurement System
      • 2.15.1 Evaluation Of A Near-infrared Automated Blood Glucose Monitor For Use In Critical Care Settings
    • 2.16 Glucose Monitoring HypoMon
      • 2.16.1 Hypoglycaemia Detection Study
      • 2.16.2 Hypoglycaemia Detection Study - Princess Margaret Hospital
    • 2.17 Glucose Monitoring Glucose Monitoring Device
      • 2.17.1 Non-Invasive Blood Glucose Measurement Using Multiple Laser Diodes
  • 3 Recent Developments
    • 3.1 Product News
      • 3.1.1 Jun 07, 2009: Medtronic Presents REAL Trend Study Results Of MiniMed Paradigm REAL-Time System At 69th Annual Scientific Sessions Of The ADA
      • 3.1.2 Jun 02, 2009: Bayer Diabetes Care Announces The Launch Of A1CNow SELFCHECK
      • 3.1.3 May 05, 2009: Bayer HealthCare Releases CONTOUR Meters In Two Bold New Colors, The Midnight Blue And Orange Burst
      • 3.1.4 Apr 27, 2009: TREE2go Receives Medical Design Excellence Award
      • 3.1.5 Apr 14, 2009: Entra Health Launches FDA Cleared Bluetooth-Enabled Blood Glucose Meter In US
      • 3.1.6 Mar 25, 2009: Sensile Medical Announces The Interim Results Of GlucoPront
      • 3.1.7 Mar 19, 2009: Accu-Chek Inform II Blood Glucose Monitoring System Helps To Improve Patient Care
      • 3.1.8 Feb 09, 2009: ARKRAY Announces FDA Approval To Market GLUCOCARD 01-mini Blood Glucose Monitoring System
      • 3.1.9 Feb 03, 2009: Accu-Chek Aviva Nano Designed To Motivate Patients For Self-Management Of Diabetes
      • 3.1.10 Nov 13, 2008: Echo Therapeutics To Present Clinical Study Results Of Its Symphony Transdermal Continuous Glucose Monitoring System
      • 3.1.11 Oct 28, 2008: Home Diagnostics Introduces TRUE2go Blood Glucose Monitoring System
      • 3.1.12 Oct 02, 2008: Tosoh G8 HPLC Analyzer For Diabetes Monitoring And HbA1c Testing Cleared By FDA
      • 3.1.13 Sep 12, 2008: LifeScan Added Two New Colors To Top-Selling OneTouch UltraMini Blood Glucose Meter
      • 3.1.14 Sep 08, 2008: Bayer Featured Redesigned MICROLET 2 Lancing System At European Association
      • 3.1.15 Sep 08, 2008: JDRF Study Results Show Continuous Glucose Monitoring Provides Significant Benefits In Management Of Type 1 Diabetes
      • 3.1.16 Aug 20, 2008: Home Diagnostics Receives FDA Clearance For TRUE2go A No-Coding Blood Glucose Monitoring System
      • 3.1.17 Aug 01, 2008: Echo Reports Positive Data For Non-Invasive Glucometer
      • 3.1.18 Jul 29, 2008: Echo Therapeutics Announces Positive Results Of A Clinical Study Of Its Symphony Transdermal Continuous Glucose Monitoring System
      • 3.1.19 Jul 23, 2008: BodyTel's Blood Glucose Monitoring And Diabetes Management System, GlucoTel, Passes TNO Tests
      • 3.1.20 Jul 18, 2008: Blood Glucose Monitoring System, The Prodigy Voice, Awarded For Its Excellent Efforts Being Accessible For The Low Vision And The Blind
      • 3.1.21 Jul 14, 2008: Echo Therapeutics Announces Publication Of Positive Clinical Data For Its Symphony Transdermal Continuous Glucose Monitoring System
      • 3.1.22 Jan 02, 2008: Echo Therapeutics Starts Clinical Study Of Its Symphony Continuous Transdermal Glucose Monitoring System
      • 3.1.23 Nov 05, 2007: Roche Launches Accu-Chek Compact Plus, The All-In-One Blood Glucose Monitoring System
    • 3.2 Product Approvals
      • 3.2.1 Feb 09, 2009: ARKRAY Announces FDA Approval To Market GLUCOCARD 01-mini Blood Glucose Monitoring System
      • 3.2.2 Oct 02, 2008: Tosoh G8 HPLC Analyzer For Diabetes Monitoring And HbA1c Testing Cleared By FDA
      • 3.2.3 Aug 20, 2008: Home Diagnostics Receives FDA Clearance For TRUE2go A No-Coding Blood Glucose Monitoring System
      • 3.2.4 Jul 23, 2008: BodyTel's Blood Glucose Monitoring And Diabetes Management System, GlucoTel, Passes TNO Tests
    • 3.3 Clinical Trials
      • 3.3.1 Jun 07, 2009: Medtronic Presents REAL Trend Study Results Of MiniMed Paradigm REAL-Time System At 69th Annual Scientific Sessions Of The ADA
      • 3.3.2 Mar 25, 2009: Sensile Medical Announces The Interim Results Of GlucoPront
      • 3.3.3 Nov 13, 2008: Echo Therapeutics To Present Clinical Study Results Of Its Symphony Transdermal Continuous Glucose Monitoring System
      • 3.3.4 Sep 08, 2008: JDRF Study Results Show Continuous Glucose Monitoring Provides Significant Benefits In Management Of Type 1 Diabetes
      • 3.3.5 Aug 01, 2008: Echo Reports Positive Data For Non-Invasive Glucometer
      • 3.3.6 Jul 29, 2008: Echo Therapeutics Announces Positive Results Of A Clinical Study Of Its Symphony Transdermal Continuous Glucose Monitoring System
      • 3.3.7 Jul 14, 2008: Echo Therapeutics Announces Publication Of Positive Clinical Data For Its Symphony Transdermal Continuous Glucose Monitoring System
  • 4 Appendix
    • 4.1 Methodology
      • 4.1.1 Coverage
      • 4.1.2 Secondary Research
      • 4.1.3 Primary Research
      • 4.1.4 Expert Panel Validation
    • 4.2 Contact Us
    • 4.3 About Global Markets Direct
    • 4.4 Disclaimer
  • 1 List of Tables
    • Table 1: Glucose Monitoring Clinical Trial By Equipment Type
    • Table 2: Glucose Monitoring Clinical Trials By Trial Phase and Trial Status
    • Table 3: Glucose Monitoring Pipeline Products By Development Stage
    • Table 4: Glucose Monitoring Pipeline Products By Therapy Area
    • Table 5: Glucose Monitoring Pipeline Products By News Summary
    • Table 6: SENTRIS-100 - First Hypoglycemic Clamping Study of Sentris-100 Completed
    • Table 7: OmniPod Personal Diabetes Manager - OmniPod Insulin Management System To Assess The Comfort, Function, And Use Of The OmniPod system (Pod) Compared With The Use Of A Conventional Insulin Pump
    • Table 8: OmniPod Personal Diabetes Manager - In Silico Benchmark Platform For Artificial Cell - A Dynamic Simulator For Closed-Loop Control With Hardware-In-The-Loop
    • Table 9: GLUCOCARD X-METER GT-1910 - Evaluation Of Glucocard X-Meter Glucose Monitoring System
    • Table 10: Scout DS - A Prospective, Multi-Center, Paired Data, Cohort Screening Trial Comparing SCOUT to the Fasting Plasma Glucose Test in Subjects at Risk for Diabetes
    • Table 11: Scout DS - Noninvasive Skin Spectroscopy For Diabetes Screening
    • Table 12: Scout DS - Noninvasive Skin Spectroscopy For Diabetes Screening
    • Table 13: Scout DS - A Calibration Trial To Assure The Ability Of Scout DS In People At Risk For Type 2 Diabetes
    • Table 14: Scout DS - A Prototype Study-Scout DS
    • Table 15: Scout DS - A Cross-Sectional Study Comparing Noninvasive Skin Fluorescence To Coronary Artery Calcification Measured By Rapid Computed Tomography
    • Table 16: Scout DS - A Cross-Sectional Study Comparing Noninvasive Skin Fluorescence To Coronary Artery Calcification Measured By Rapid Computed Tomography
    • Table 17: Non-invasive continuous glucose monitor - Repetition Trial at the University Hospital Zrich
    • Table 18: Non-invasive continuous glucose monitor - Solianis' Multisensor System In Home-Use Trial
    • Table 19: SpectRx Glucose Monitoring - CDC Study Shows Spectrx Continuous Glucose Monitor Tracks Glucose Levels In Children And Adults
    • Table 20: Sensys GTS - Evaluation of a non-invasive glucose monitor through an independent multi-center clinical study
    • Table 21: NBM-200G - The accuracy, safety and efficacy of the NBM-200G were demonstrated in a clinical trial which assessed a full range of blood glucose levels and a variety of glucose monitoring applications
    • Table 22: NBM-200G - Performance Of A Non-Invasive Continuous Glucose Monitor In A Multi-Center Clinical Trial
    • Table 23: OneTouch Glucose Meter - A 54 Week Open, Randomized, Parallel Arm, Controlled Study Designed to Assess the Clinical Benefit of the OneTouch Ultra2 System
    • Table 24: Luminous Medical Glucose Measurement System - Evaluation Of A Near-infrared Automated Blood Glucose Monitor For Use In Critical Care Settings
    • Table 25: HypoMon - Hypoglycaemia Detection Study
    • Table 26: HypoMon - Hypoglycaemia Detection Study - Princess Margaret Hospital
    • Table 27: Glucose Monitoring Device - Non-Invasive Blood Glucose Measurement Using Multiple Laser Diodes
  • 1.2 List of Figures
    • Figure 1: Global Markets Direct Methodology